INTRODUCTION The popularity of soft tissue fillers for facial rejuvenation is increasing. Aesthetic use of fillers gained momentum, safety and reliability with the successive introductions of several non-animal derived products…
Read More
INTRODUCTIONBotulinum toxin type A (BoNT-A) has been used for almost 20 years in cosmetic dermatology to reduce various facial dynamic wrinkles and for other cosmetic indications.1 The clinical benefits occur…
Read More
INTRODUCTIONThe clinical benefits of botulinum toxin type A (BoNT-A) in cosmetic dermatology occur very quickly, and can be seen approximately 2 to 4 days1 after the injections, with an average…
Read More
INTRODUCTION Neck rejuvenation is becoming increasingly popular for individuals in their 40’s and older. As the neck ages, it loses the well-defined contours seen in youth. One apparent change is…
Read More
INTRODUCTIONResveratrol (3,5,4’-trihydroxystilbene) was first isolated from the roots of white hellebore (Veratrum grandiflorum O. Loes) and later from the roots of Polygonum cuspidatum.(1) This plant has long been used in…
Read More
INTRODUCTION The aging of our largest organ, the integument, results from both intrinsic and extrinsic factors. This proposed terminology Generational Dermatology encompasses prevention and involves medical, cosmetic, surgical and oncologic…
Read More
INTRODUCTIONThe anti-inflammatory properties of a topically-applied corticosteroid (CS) have been well recognized since the discovery of Compound F (hydrocortisone) in 1949.1 In 1958, dexamethasone was introduced after a search for…
Read More
INTRODUCTION Verrucae, commonly known as warts, are caused by the human papillomavirus (HPV). Humans are the primary reservoir for this virus. Infection with HPV is exceedingly commonplace, and it is…
Read More
INTRODUCTIONTraditional skin resurfacing CO2 laser devices, though highly effective in tissue coagulation, are associated with prolonged recovery time, bleeding, oozing, and risk of post treatment hyper or hypopigmentation.1-5 In addition,…
Read More
INTRODUCTION The use of botulinum toxin as a therapeutic agent was pioneered by an ophthalmologist around 30 years ago for use in strabismus and blepharospasm.1,2 In the following decades, botulinum…
Read More
INTRODUCTIONCutaneous HP can produce profound psychosocial impacts depending upon one’s race and personality. It is the second most common complaint in dermatologist’s offices by African American patients, while 11th in…
Read More
INTRODUCTION One of the biggest challenges in managing plaque psoriasis is lack of adherence to treatments by patients, which negatively affects treatment outcomes.1 Forty percent of surveyed subjects with plaque…
Read More






